PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ACAD vs. ABT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


ACADABT
YTD Return-52.92%5.09%
1Y Return-33.69%24.37%
3Y Return (Ann)-6.38%-2.37%
5Y Return (Ann)-19.11%8.18%
10Y Return (Ann)-6.13%12.18%
Sharpe Ratio-0.581.40
Sortino Ratio-0.641.99
Omega Ratio0.911.25
Calmar Ratio-0.430.77
Martin Ratio-0.813.09
Ulcer Index39.75%7.96%
Daily Std Dev55.93%17.58%
Max Drawdown-96.29%-45.62%
Current Drawdown-74.14%-15.20%

Fundamentals


ACADABT
Market Cap$2.45B$198.47B
EPS$0.19$3.27
PE Ratio77.5834.68
PEG Ratio-0.422.22
Total Revenue (TTM)$678.84M$41.22B
Gross Profit (TTM)$619.76M$22.55B
EBITDA (TTM)$90.33M$7.79B

Correlation

-0.50.00.51.00.3

The correlation between ACAD and ABT is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

ACAD vs. ABT - Performance Comparison

In the year-to-date period, ACAD achieves a -52.92% return, which is significantly lower than ABT's 5.09% return. Over the past 10 years, ACAD has underperformed ABT with an annualized return of -6.13%, while ABT has yielded a comparatively higher 12.18% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%MayJuneJulyAugustSeptemberOctober
-11.79%
8.09%
ACAD
ABT

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ACAD vs. ABT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ACADIA Pharmaceuticals Inc. (ACAD) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ACAD
Sharpe ratio
The chart of Sharpe ratio for ACAD, currently valued at -0.58, compared to the broader market-4.00-2.000.002.004.00-0.58
Sortino ratio
The chart of Sortino ratio for ACAD, currently valued at -0.64, compared to the broader market-4.00-2.000.002.004.006.00-0.64
Omega ratio
The chart of Omega ratio for ACAD, currently valued at 0.91, compared to the broader market0.501.001.502.000.91
Calmar ratio
The chart of Calmar ratio for ACAD, currently valued at -0.43, compared to the broader market0.002.004.006.00-0.43
Martin ratio
The chart of Martin ratio for ACAD, currently valued at -0.81, compared to the broader market-10.000.0010.0020.0030.00-0.81
ABT
Sharpe ratio
The chart of Sharpe ratio for ABT, currently valued at 1.40, compared to the broader market-4.00-2.000.002.004.001.40
Sortino ratio
The chart of Sortino ratio for ABT, currently valued at 1.99, compared to the broader market-4.00-2.000.002.004.006.001.99
Omega ratio
The chart of Omega ratio for ABT, currently valued at 1.25, compared to the broader market0.501.001.502.001.25
Calmar ratio
The chart of Calmar ratio for ABT, currently valued at 0.77, compared to the broader market0.002.004.006.000.77
Martin ratio
The chart of Martin ratio for ABT, currently valued at 3.09, compared to the broader market-10.000.0010.0020.0030.003.09

ACAD vs. ABT - Sharpe Ratio Comparison

The current ACAD Sharpe Ratio is -0.58, which is lower than the ABT Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of ACAD and ABT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50MayJuneJulyAugustSeptemberOctober
-0.58
1.40
ACAD
ABT

Dividends

ACAD vs. ABT - Dividend Comparison

ACAD has not paid dividends to shareholders, while ABT's dividend yield for the trailing twelve months is around 1.94%.


TTM20232022202120202019201820172016201520142013
ACAD
ACADIA Pharmaceuticals Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ABT
Abbott Laboratories
1.94%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%1.95%1.46%

Drawdowns

ACAD vs. ABT - Drawdown Comparison

The maximum ACAD drawdown since its inception was -96.29%, which is greater than ABT's maximum drawdown of -45.62%. Use the drawdown chart below to compare losses from any high point for ACAD and ABT. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%MayJuneJulyAugustSeptemberOctober
-74.14%
-15.20%
ACAD
ABT

Volatility

ACAD vs. ABT - Volatility Comparison

ACADIA Pharmaceuticals Inc. (ACAD) has a higher volatility of 8.11% compared to Abbott Laboratories (ABT) at 4.59%. This indicates that ACAD's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%MayJuneJulyAugustSeptemberOctober
8.11%
4.59%
ACAD
ABT

Financials

ACAD vs. ABT - Financials Comparison

This section allows you to compare key financial metrics between ACADIA Pharmaceuticals Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items